These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 25805399)

  • 1. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients.
    Miyoshi S; Shien K; Toyooka S; Miyoshi K; Yamamoto H; Sugimoto S; Soh J; Hayama M; Yamane M; Oto T
    Surg Today; 2014 Nov; 44(11):2028-36. PubMed ID: 24170276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer.
    Cerfolio RJ; Bryant AS; Minnich DJ
    Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
    Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
    Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
    Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
    Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
    J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of lymph node involvement with the prognosis of pathological T1 invasive non-small cell lung cancer.
    Zhang YK; Chai ZD; Tan LL; Wang ZY; Chen ZJ; Le HB; Zhu WY
    World J Surg Oncol; 2017 Mar; 15(1):64. PubMed ID: 28302176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis.
    Kuroda H; Sakao Y; Mun M; Uehara H; Nakao M; Matsuura Y; Mizuno T; Sakakura N; Motoi N; Ishikawa Y; Yatabe Y; Nakagawa K; Okumura S
    PLoS One; 2015; 10(8):e0134674. PubMed ID: 26247881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of occult pN2 disease following resection and mediastinal lymph node dissection in clinical stage I lung cancer patients.
    Bille A; Woo KM; Ahmad U; Rizk NP; Jones DR
    Eur J Cardiothorac Surg; 2017 Apr; 51(4):674-679. PubMed ID: 28200091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
    Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
    Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
    Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
    Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer.
    Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH
    Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.